Looking at top Wall Street opinions, Nutrien Ltd. (NYSE: NTR) has recently made its way into the research list of Cowen – signaling that their analyst’s rating adjustment is noteworthy. This stock was Reiterated to a rating of Outperform in the eyes of Cowen, as reported on Tuesday, April 23rd, 2019. Another heavy-hitting research note was published by Cowen on Wednesday March 6th, 2019, with this firm Reiterated NTR to an updated rating of Outperform. In the past six months and three months of trading, shares of Nutrien Ltd. (NTR) have moved by -6.88% and 0.76%, respectively.
Brokerage Updates Related to Nutrien Ltd. (NTR) Stock
This publicly-traded organization generated losses of -2.56% over the last 5 sessions. Right now, this stock is the subject of 13 analysts’ evaluations, who – on average – have given this company’s shares a Buy rating. Of the latest market expert opinions, 1 have given an underperform rating, 0 has given a sell rating, and 5 have given a rating of Buy or better. Based on the 13 stock market experts following this company, the average 12-month price target is $58.28. Moreover, individual price targets range between $70.91-$92.24. With its recent move to $84.33, we can see that these firms project this stock will loss by -12.00% in one year.
Updates from Nutrien Ltd. (NTR) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 54.60% rise since the beginning of the calendar year.
Nutrien Ltd. (NYSE:NTR) Results in the Pipeline
The next scheduled release of financial results for Nutrien Ltd. will be for the Jun-19 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $1.60. In the same vein, they expect sales for the quarter to amount to $8,630.90 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $8,657.00 million in revenue alongside EPS at $1.58. On average, the analyst projection was calling for $3,691.00 million with $0.20 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $3,762.00 million, with earnings per share ending up at $0.54.
ArQule, Inc. (NASDAQ:ARQL) experienced a gain of 3.44% from the closing price in the previous trading day. That boost the price to $9.01 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 1,652,668 shares of stock – compared to the typical average of 3.34M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $12.69.
Pricing Indications for ArQule, Inc. (ARQL)
This organization has had a price-to-earnings ratio of in the last year. Meanwhile, it gained 9.70 from its observable 50-day simple moving average. Right at this moment, the per-share value is 56.68% higher than the mean per-share price over the last 200 days in the market.
ArQule, Inc. (NASDAQ:ARQL) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 2 have a Buy rating, 6 have an outperform rating, while 0 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 1.70 , based on information from Thomson Reuters.
ARQL Stock Value Potential
In trading activity as of late, this stock’s value was 5.78 up from its 200 day moving average, while also -6.79% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $11.00-$18.00. The market value for the entire organization reached 1.08B. In the last trading session, the price ended the day at $8.71. The institutional holdings related to this organization account for 1.00%, and the Beta factor is now 2.29. This company’s RSI (Relative Strength Index) managed to hit 41.95.
ArQule, Inc. (NASDAQ:ARQL) Analyst Points of Focus
ArQule, Inc. (ARQL) has found itself inside of RBC Capital Mkts’s research list, so their analyst rating adjustment is worth taking note of. This stock was Initiated to Outperform, by RBC Capital Mkts, as garnered from a news report on Thursday April 11th, 2019. An additional helpful research note was sent out by Needham’s on Monday June 18th, 2018. The brokerage decided to reiterated ARQL to Buy.